Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Kalvista Pharmaceuticals Inc (KALV)

$16.22 0.24 (1.46%)

15:52 EST KALV Stock Quote Delayed 15 Minutes

Volume:

Previous Close $16.46

Market Cap 175.11M

PE Ratio -35.26

EPS -0.46

Volume (Avg. Vol.) 44,378

Day's Range 16.13 - 16.56

52-Week Range 9.86 - 34.92

Dividend & Yield N/A (N/A)

KALV Stock Predictions, Articles, and Kalvista Pharmaceuticals Inc News

From InvestorPlace
From the Web

5 Stocks to Buy Based on Insider Buying

By Mark Putrino, CMT Oct 8, 2019

These are five stocks to consider buying because of significant insider buying activity. Insiders only buy for one reason: to make money.

BioLineRx Concludes Recruitment in Pancreatic Cancer Study

From Zacks Investment Research Jan 23, 2020

BioLineRx (BLRX) closes patient recruitment in the triple combination arm of the phase IIa COMBAT/KEYNOTE-202 study on Motixafortide to treat second-line metastatic pancreatic cancer.

Will KalVista Continue to Surge Higher?

From Zacks Investment Research Jan 23, 2020

As of late, it has definitely been a great time to be an investor in KalVista Pharmaceuticals.

Prospects Appear Bright for Small Drug Industry in 2020

From Zacks Investment Research Jan 21, 2020

Successful innovation resulting in new drug approvals, important advances in clinical studies, frequent collaborations and M&A activity keep small drugmakers afloat in a competitive market.

Here’s Why We’re Not Too Worried About KalVista Pharmaceuticals’s (NASDAQ:KALV) Cash Burn Situation

From Simply Wall St Jan 20, 2020

There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kalv/kalvista-pharmaceuticals/news/heres-why-were-not-too-worried-about-kalvista-pharmaceuticalss-nasdaqkalv-cash-burn-situation/">Read More...</a></div>

Is KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) A Volatile Stock?

From Simply Wall St Jan 2, 2020

If you’re interested in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kalv/kalvista-pharmaceuticals/news/is-kalvista-pharmaceuticals-inc-nasdaqkalv-a-volatile-stock/">Read More...</a></div>

Will KalVista Continue to Surge Higher?

From Zacks Investment Research Jan 2, 2020

As of late, it has definitely been a great time to be an investor in KalVista.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold